Todas as matérias desta categoria, das mais recentes às mais antigas.
Intel (NASDAQ:INTC) shares vaulted 14% to a record high on Tuesday, fueled by a Bloomberg report that Apple (NASDAQ:AAPL) has initiated early-stage discussions with both Intel and Samsung Electronics about manufacturing its flagship processors within the United States.
Rockwell Automation (NYSE:ROK) reported significant top- and bottom-line growth for its fiscal second quarter, as the company’s pivot toward software-driven industrial solutions and smart manufacturing hardware continues to gain traction globally.
Duke Energy (NYSE:DUK) delivered a robust start to 2026, reporting a significant year-over-year earnings jump as the utility giant benefited from intensive infrastructure spending and favorable weather patterns across its core jurisdictions.
UL Solutions (NYSE:ULS) delivered a powerful performance in its first quarter of 2026, characterized by high organic growth and a sharp expansion in profitability that exceeded market expectations.
Marriott Vacations Worldwide (NYSE:VAC) reported a softer start to 2026, as a slight dip in contract sales and a shift in the financing environment pressured the bottom line.
IDEAYA Biosciences (NASDAQ:IDYA) marked a milestone first quarter in 2026, transitioning into a late-stage regulatory company following a decisive clinical win in its lead oncology program and the initiation of a rolling New Drug Application (NDA).
Integra LifeSciences (NASDAQ:IART) signaled a turning point in its operational recovery today, raising its full-year profit guidance even as it recorded a GAAP loss during a quarter defined by significant leadership changes and supply chain stabilization.
Enlight Renewable Energy 9NASDAQ:ENLT) delivered a high-growth first quarter, reporting a 54% increase in total revenues and income as the company aggressively scales its combined solar and storage portfolio across the United States, Europe, and the Middle East.
KBR (NYSE:KBR) reported a resilient start to fiscal 2026, leveraging a record-high backlog to navigate a temporary decline in revenue as large-scale contingency work in Europe begins to wind down.
Pediatrix Medical Group (NYSE:MD) reported first-quarter earnings that beat Wall Street estimates on both the top and bottom lines, as favorable reimbursement shifts helped the physician services leader overcome a softer volume environment.
Fortrea (NASDAQ:FTRE) reported a steady start to 2026, characterized by robust new business wins and a growing backlog that provides a solid foundation for the company as it navigates its second full year as a standalone clinical research organization (CRO).
Henry Schein (NASDAQ:HSIC) delivered a solid start to 2026, reporting a 6.3% increase in total net sales as the company’s core dental business benefited from resilient patient volumes and a strategic push into the value implant market.
